Adding MS drug to targeted cancer therapy may improve glioblastoma outcomes

The multiple sclerosis drug teriflunomide, paired with targeted cancer therapy, markedly shrinks patient-derived glioblastomas grown in mice by reaching stem cells at the tumor’s root, according to a new study.

Share this post:


 

Recent Posts